QUIDELORTHO CORP Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
QUIDELORTHO CORP (QDEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 120.00 thousand shares for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2026-02-19
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2023-01-01 was -24.00K shares.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2025 was 120.00K shares, a 75.61% decline from fiscal 2024.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2024 was 492.00K shares, a 472.09% increase from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 86.00K shares, a 13.16% increase from fiscal 2023.
- QUIDELORTHO CORP share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 76.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|---|
| 2025-12-28 | 120.00K shares 10-K · filed 2026-02-19 | ||
| 2024-12-29 | 492.00K shares 10-K · filed 2025-02-27 | ||
| 2023-12-31 | 86.00K shares 10-K/A · filed 2024-08-01 | ||
| 2023-01-01 | -24.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 76.00K shares 10-K · filed 2023-02-23 | |
| 2022-10-02 | 100.00K shares 10-Q · filed 2022-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |